Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate

Since reduced antithrombin III (AT III) activity are associated with increased risk of thromboembolism, we have determined it in 39 patients with prostatic carcinoma. Pre-treatment levels were determined in 24 patients, 6 additional patients with prostatic carcinoma on estrogen treatment and 9 patie...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 35(1989), 5 vom: 15. Mai, Seite 807-13
1. Verfasser: Hayashi, T (VerfasserIn)
Weitere Verfasser: Takenawa, J, Ryoji, O, Hiura, M, Taki, Y, Kiriyama, T
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1989
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Comparative Study English Abstract Journal Article Estrogens Chlormadinone Acetate 0SY050L61N Ethinyl Estradiol 423D2T571U Diethylstilbestrol 731DCA35BT mehr... Antithrombin III 9000-94-6